An Empirical Analysis of Primary and Secondary Pharmaceutical Patents in Chile
NBER Working Paper No. 20995
---- Acknowledgments ----
The authors thank INAPI (in particular the pharmaceutical patents team), as well as Aisen Etcheverry, Catalina Olivos Besserer, Maria Lorena Chacon, and Alhena Fuentes for their generous support in constructing the data. We also thank representatives of ASILFA and Camara de la Innovacion Farmaceutica for insightful discussions. We also benefitted from the comments of two anonymous referees, Carsten Fink, Catalina Martinez, Keith Maskus, and participants of the 2014 Meide conference in Santiago and seminars at INAPI, UC Berkeley, and UC Davis.
The data construction effort for this paper was partially funded by the World Intellectual Property Association, with additional support from the United Nations University-MERIT and Santa Clara University. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.